UW Cancer Center Johnson Creek
250 Doctors Ct
Johnson Creek, Wisconsin 53038
(920) 699-3500 http://www.uwjohnsoncreek.org mmoody@uwhealth.org
Johnson Creek, Wisconsin 53038
(920) 699-3500 http://www.uwjohnsoncreek.org mmoody@uwhealth.org
UW Cancer Center Johnson Creek is a collaboration between Fort HealthCare, UW Health and UW Health Partners Watertown Regional Medical Center that will provide convenient, comprehensive care for the people of southeastern Wisconsin.
Our 14,300 square-foot facility, located adjacent to the Johnson Creek Medical Center, offers prevention, education and treatment for virtually all types of cancers. Our patients have local access to medical and radiation oncology services, chemotherapy treatments and clinical trials beginning in the fall of 2005.
We've found
41 trials
at this facility
Oncology Clinical Trial
Updated: 8/14/2012
Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 8/14/2012
Click here to add this to my saved trials
Lymphoma Clinical Trial
Updated: 3/13/2015
Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma
Status: Enrolling,
Phase
II
Updated: 3/13/2015
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/8/2015
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/8/2015
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 11/18/2013
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Status: Enrolling
Updated: 11/18/2013
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Updated: 9/16/2014
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling,
Phase
II
Updated: 9/16/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 1/26/2016
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling,
Phase
III
Updated: 1/26/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/17/2016
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 3/17/2016
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Updated: 9/19/2014
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
Status: Enrolling,
Phase
II
Updated: 9/19/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/16/2014
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Status: Enrolling,
Phase
III
Updated: 9/16/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 4/5/2016
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Status: Enrolling,
Phase
III
Updated: 4/5/2016
Click here to add this to my saved trials
Anal Cancer Clinical Trial
Updated: 8/22/2012
Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer
Status: Enrolling,
Phase
II
Updated: 8/22/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 4/16/2014
Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 4/16/2014
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Updated: 9/3/2015
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Status: Enrolling,
Phase
III
Updated: 9/3/2015
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/19/2013
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/19/2013
Click here to add this to my saved trials
Brain and Central Nervous System Tumors Clinical Trial
Updated: 4/6/2011
Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma
Status: Enrolling
Updated: 4/6/2011
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 4/4/2016
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 4/4/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 4/5/2016
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Status: Enrolling,
Phase
III
Updated: 4/5/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 9/18/2014
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 9/18/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 1/29/2016
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 1/29/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/16/2016
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 3/16/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/16/2016
Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 3/16/2016
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 3/22/2016
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 3/22/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 4/5/2016
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Status: Enrolling,
Phase
III
Updated: 4/5/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/29/2016
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 3/8/2016
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/8/2016
Click here to add this to my saved trials
Metastatic Hormone-sensitive Prostate Cancer Clinical Trial
Updated: 2/1/2016
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 2/1/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 4/5/2016
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Status: Enrolling,
Phase
III
Updated: 4/5/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 4/5/2016
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/5/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 4/5/2016
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Status: Enrolling,
Phase
III
Updated: 4/5/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 4/5/2016
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Status: Enrolling,
Phase
III
Updated: 4/5/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 4/5/2016
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
Status: Enrolling,
Phase
III
Updated: 4/5/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 4/5/2016
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 4/5/2016
Click here to add this to my saved trials
Untreated Adult Acute Myeloid Leukemia Clinical Trial
Updated: 4/5/2016
Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia
Status: Enrolling,
Phase
III
Updated: 4/5/2016
Click here to add this to my saved trials
Clinical Trial
Updated: 4/5/2016
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
Status: Enrolling,
Phase
III
Updated: 4/5/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 4/4/2016
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
Status: Enrolling,
Phase
II
Updated: 4/4/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 4/5/2016
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Status: Enrolling,
Phase
III
Updated: 4/5/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 4/5/2016
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling,
Phase
III
Updated: 4/5/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 4/5/2016
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer or Metastatic Large Cell Neuroendocrine Non-small Cell Lung Cancer
Status: Enrolling,
Phase
I, II
Updated: 4/5/2016
Click here to add this to my saved trials
Clinical Trial
Updated: 4/5/2016
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Status: Enrolling,
Phase
III
Updated: 4/5/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/9/2016
Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 2/9/2016
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 2/1/2016
Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
II
Updated: 2/1/2016
Click here to add this to my saved trials